ClinVar Miner

Submissions for variant NM_000174.5(GP9):c.284A>G (p.Tyr95Cys)

dbSNP: rs1946583076
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV003230887 SCV003928827 uncertain significance not specified 2023-04-24 criteria provided, single submitter clinical testing Variant summary: GP9 c.284A>G (p.Tyr95Cys) results in a non-conservative amino acid change to a highly conserved residue (HGMD) located in the Cysteine-rich flanking region, C-terminal (IPR000483) of the encoded protein sequence. Another missense variant affecting this residue has been found in association with disease (HGMD). Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 244960 control chromosomes (gnomAD). c.284A>G has been reported in the literature in an individual affected with Bernard Soulier Syndrome (Savoia_2011). These data indicate that the variant may be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. No submitters have provided clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic.
Institute for Clinical Chemistry and Laboratory Medicine, University Medical Center Mainz RCV003329136 SCV004031420 pathogenic Bernard Soulier syndrome 2023-09-04 criteria provided, single submitter clinical testing We identified this missense variant (284A>G) in one affected indiviudal of an Iranian family (PMID: 32202057; wrongly named 284G>A) which was diagnosed as having Bernard-Soulier syndrome (BSS) by Shahverdi et al (PMID: 29043243) (giant platelets, thrombocytopenia, bleeding phenotype, impaired platelet aggregation with ristocetin). The index case (daughter) was homozygous for GP9 c.284A>G, her asymptomatic parents heterozygous. She also presented with prekallikrein deficiency due to a larger deletion in KLKB1. GP9 c.284A>G can be found in dbSNP with a MAF <0.01% (rs1946583076) and prediction tools predict pathogenicity. GP9 is known to cause BSS and this exact variant was also identified as the cause of BSS in homozygosity in an unrelated case by Savoia et al (PMID: 21173099). Therfore, we classified this variant as pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.